The Impact of Chronic Urticaria from the Patient’s Perspective: A Survey in Five European Countries

Patient

Volumn 8, Issue 6, 2015, Pages 551-558

  Balp, Maria Magdalena ^a   Vietri, Jeffrey ^b   Tian, Haijun ^a   Isherwood, Gina ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b KANTAR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; ANXIETY; ARTICLE; CHRONIC URTICARIA; CONSULTATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; EMERGENCY WARD; EUROPE; FEMALE; FRANCE; GERMANY; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOSPITALIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL COMPONENT SUMMARY; MENTAL DISEASE; PHYSICAL COMPONENT SUMMARY; PHYSICAL DISEASE; PRESCRIPTION; PRESENTEEISM; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SELF REPORT; SF 6D HEALTH UTILITY SCORE; SLEEP DISORDER; SPAIN; UNITED KINGDOM; WORK; WORK DISABILITY; AGE; CHRONIC DISEASE; COST OF ILLNESS; HEALTH BEHAVIOR; HEALTH SERVICE; MENTAL HEALTH; MIDDLE AGED; PSYCHOLOGY; SEX DIFFERENCE; SLEEP; SOCIOECONOMICS; URTICARIA; UTILIZATION;

ABSENTEEISM; ADULT; AGE FACTORS; ANXIETY; CHRONIC DISEASE; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DEPRESSION; EUROPE; FEMALE; HEALTH BEHAVIOR; HEALTH SERVICES; HEALTH SURVEYS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; QUALITY OF LIFE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SLEEP; SOCIOECONOMIC FACTORS; URTICARIA;

EID: 84948586851     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-015-0145-9     Document Type: Article

References (23)

1. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Walter Canonica G, et al. The EAACI/GA2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2013;2014(69):868–87.
2. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004;114(3):465–74.
3. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105(4):664–72.
4. Maurer M, Weller K, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011;66:317–30.
5. Hellgren L. The prevalence of urticaria in the total population. Acta Allergol. 1972;27:236–40.
6. Gaig P, Olona M, Munoz Lejarazu D, Caballero M, Dominguez F, Echechipia S, et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol. 2004;14:214–20.
7. Bakke P, Gulsvik A, Eide G. Hay fever, eczema and urticaria in southwest Norway: lifetime prevalences and association with sex, age, smoking habits, occupational airborne exposures and respiratory symptoms. Allergy. 1990;45:515–22.
8. Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010;35(8):869–73.
9. Weldon DR. Quality of life in patients with urticaria. Allergy Asthma Proc. 2006;27:96–9.
10. O’Donnell BF. Urticaria: impact on quality of life and economic cost. Immunol Allergy Clin N Am. 2014;34:89–104.
11. Kang MJ, Kim HS, Kim HO, Park YM. The impact of chronic idiopathic urticaria on quality of life in Korean patients. Ann Dermatol. 2009;21(3):226–29.
12. Staubach P, Eckhardt-Henn A, Dechene M, Vonend A, Metz M, Magerl M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. 2006;154:294–8.
13. Bolge SC, Doan JF, Kannan H, Baran RW. Association of insomnia with quality of life, work productivity, and activity impairment. Qual life Res. 2009;18(4):415–22.
14. Liu GG, Dibonaventura MD, Yuan Y, et al. The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan. Value Health. 2012;15(1):S65–71.
15. Ware J, Kosinski M, Turner-Bowker DM, Gandek B. How to score version 2 of the SF-12 health survey. Lincoln: Quality Metric Incorporated; 2002.
16. Maruish ME, editor. User’s manual for the SF-36v2 Health Survey, 3rd edn. Lincoln: Quality Metric Incorporated; 2011.
17. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851.
18. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353.
19. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.
20. Overton WS, Stehman SV. The Horvitz-Thompson theorem as a unifying perspective for probability sampling: with examples from natural resource sampling. Am Stat. 1995;49:261–8.
21. Current Population Survey, 2013 Annual Social and Economic (ASEC) Supplement [machine-readable data file]/conducted by the Bureau of the Census for the Bureau of Labor Statistics. Washington: US Census Bureau [producer and distributor]; 2013.
22. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582.
23. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–32.